Saturday, September 27, 2025

Trump to put import taxes on pharma, home furnishings, heavy trucks




By AP with Eleanor Butler
Published on 26/09/2025 -

While Trump did not provide a legal justification for the tariffs, he appeared to stretch the bounds of his role as commander-in-chief by stating on Truth Social that the taxes on imported kitchen cabinets and sofas were needed “for national security and other reasons".

President Donald Trump said on Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on 1 October.

The posts on his social media site showed that Trump's devotion to tariffs did not end with the trade frameworks and import taxes that were launched in August, a reflection of the president's confidence that taxes will help to reduce the government's budget deficit while increasing domestic manufacturing.

While Trump did not provide a legal justification for the tariffs, he appeared to stretch the bounds of his role as commander-in-chief by stating on Truth Social that the taxes on imported kitchen cabinets and sofas were needed “for National Security and other reasons".

Under the Trade Expansion Act of 1962, the administration launched a Section 232 investigation in April about the impacts on national security from pharmaceutical drug and truck imports. The Commerce Department launched a 232 investigation into timber and lumber in March, though it's unclear whether the furniture tariffs stem from that.


Economic uncertainty


The tariffs are another dose of uncertainty for the US economy with a solid stock market but a weakening outlook for jobs and elevated inflation. These new taxes on imports could pass through to consumers in the form of higher prices and dampen hiring, a process that economic data suggests is already underway.

“We have begun to see goods prices showing through into higher inflation,” Federal Reserve Chair Jerome Powell warned in a recent news conference, adding that higher costs for goods account for “most” or potentially “all” of the increase in inflation levels this year.

The president has pressured Powell to resign, arguing that the Fed should cut its benchmark interest rates more aggressively because inflation is no longer a concern. Fed officials have stayed cautious on rate cuts because of the uncertainty created by tariffs.

Trump said on Truth Social that the pharmaceutical tariffs would not apply to companies that are building manufacturing plants in the United States, which he defined as either “breaking ground” or being “under construction.” It was unclear how the tariffs would apply to companies that already have factories in the US.

In 2024, America imported nearly $233 billion (€199.5bn) in pharmaceutical and medicinal products, according to the Census Bureau. The prospect of prices doubling for some medicines could send shock waves to voters as healthcare expenses, as well as the costs of Medicare and Medicaid, potentially increase.

The pharmaceutical drug announcement was shocking as Trump has previously suggested that tariffs would be phased in over time so that companies had time to build factories and relocate production. On CNBC in August, Trump said he would start by charging a “small tariff” on pharmaceuticals and raise the rate over a year or more to 150% and even 250%.

According to the White House, the threat of tariffs earlier this year contributed to many major pharmaceutical companies, including Johnson & Johnson, AstraZeneca, Roche, Bristol Myers Squibb and Eli Lilly, among others, to announce investments in US production.

Pascal Chan, vice president for strategic policy and supply chains at the Canadian Chamber of Commerce, warned that the tariffs could harm Americans' health with “immediate price hikes, strained insurance systems, hospital shortages, and the real risk of patients rationing or foregoing essential medicines".

The new tariffs on cabinetry could further increase the costs for homebuilders at a time when many people seeking to buy a house feel priced out by the mix of housing shortages and high mortgage rates. The National Association of Realtors on Thursday said there were signs of price pressures easing as sales listings increased 11.7% in August from a year ago.
Investing in domestic production

Trump said that foreign-made heavy trucks and parts are hurting domestic producers that need to be defended.

“Large Truck Company Manufacturers, such as Peterbilt, Kenworth, Freightliner, Mack Trucks, and others, will be protected from the onslaught of outside interruptions,” Trump posted.

Trump has long maintained that tariffs are the key to forcing companies to invest more in domestic factories. He has dismissed fears that importers would simply pass along much of the cost of the taxes to consumers and businesses in the form of higher prices.

His broader country-by-country tariffs relied on declaring an economic emergency based on a 1977 law, a drastic tax hike that two federal courts said exceeded Trump's authority as president. The Supreme Court is set to hear the case in November.

The president continues to claim that inflation is no longer a challenge for the US economy, despite evidence to the contrary. The consumer price index has increased 2.9% over the past 12 months, up from an annual pace of 2.3% in April, when Trump first launched a sweeping set of import taxes.

Nor is there evidence that the tariffs are creating factory jobs or more construction of manufacturing facilities. Since April, the Bureau of Labor Statistics has reported that manufacturers cut 42,000 jobs and builders have downsized by 8,000.

“There’s no inflation,” Trump told reporters Thursday. “We’re having unbelievable success.”

Still, Trump also acknowledged that his tariffs against China had hurt American farmers, who lost out on sales of soybeans. The president separately promised on Thursday to divert tariff revenues to the farmers hurt by the conflict, just as he did during his first term in 2018 and 2019 when his tariffs led to retaliation against the agricultural sector.


The nations and firms threatened by Trump’s pharma tariffs


By AFP
September 26, 2025


Image: — © AFP/File TIMOTHY A. CLARY

Anne Padieu with AFP's European bureaus, 

Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products — unless companies are building manufacturing plants in the United States.

With just five days left until the US president is set to impose the harshest measures yet in his global trade war, analysts have been racing to figure out which nations, firms and drugs could be affected.

While plenty of uncertainty remains, there do appear to be some exemptions. Major exporter the European Union says a previous trade deal shields the bloc from the tariffs.

– Which products will be hit? –

Trump announced late Thursday he would impose a 100-percent tariff on “any branded or patented Pharmaceutical Product” unless the company has started construction on a manufacturing plant by October 1.

The statement indicates that generic medicines — cheaper versions of drugs produced once patents expire — are exempt.

Neil Shearing, an economist at Capital Economics, said this exemption would have limited impact because while “90 percent of US drugs consumption volumes go toward generic drugs”, they account for “just 10 percent or so of spending values”.

Kathleen Brooks, research director at XTB, said that “most of the big pharma producers already produce their drugs for the American market in the US”.

However there are many popular exceptions — such as the blockbuster weight-loss drugs Wegovy and Mounjaro — as well as some cancer treatments that are all made in Europe, she added.

Last year, the US imported nearly $252-billion worth of drugs and other pharma products, making it the second-largest import in value after vehicles, according to the Department of Commerce.

– Which countries could be spared? –

The EU said Friday that a trade deal sealed with the US in July shielded the bloc.

“This clear all-inclusive 15 percent tariff ceiling for EU exports represents an insurance policy that no higher tariffs will emerge for European economic operators,” EU trade spokesman Olof Gill said.

Tariffs on medicine “would create the worst of all worlds” by increasing costs, disrupting supply chains and preventing patients from getting life-saving treatment, Nathalie Moll of the European Federation of Pharmaceutical Industries and Associations said in a statement to AFP.

Macro Angel Talavera from Oxford Economics said the July trade deal should in principle protect EU companies– but it remains “far from clear”.

Switzerland — which is home to pharma giants Roche, Novartis and AstraZeneca — was likely most at risk because the country is not a member of the EU, he said.

Denmark, where Ozempic and Wegovy producer Novo Nordisk has a major impact on the national economy, was also under threat, he added.

The pharma sector in Ireland — whose exports to the US represent roughly 12 percent of GDP, according to Shearing — was among the European groups calling for urgent talks to avert the looming tariffs.

A British government spokesperson said the UK was “actively engaging with the US and will continue to do so over the coming days”.

In Asia, Japan and South Korea are thought to be shielded by trade deals, while India mostly exports generic drugs, according to Louise Loo at Oxford Economics.

“Singapore, focused on high-value patented drugs, faces the greatest risk,” she added.

– What are pharma firms doing? –

Trump had previously threatened even steeper tariffs of 200 percent on pharmaceuticals in July.

Aiming to protect themselves from Trump’s protectionist policies, pharma giants have announced around $300 million in investments in the US in recent months.

“Although many pharma companies have pledged to build plants in the US, construction may not have started yet, as these plants are complex to build,” Brooks said.

However Trump was clear that he defined building as “breaking ground” on construction sites.

Swiss pharma giant Novartis said on Friday that “we have ongoing construction and expect to announce five new sites to be under construction before end of year”.

A spokesperson for Bayer said the German company was “assessing the situation”. Other major firms contacted by AFP have yet to respond.

Trump announces steep new tariffs, reviving trade war


By AFP
September 25, 2025


US President Donald Trump has announced a fresh round of tariffs on drugs, big-rig trucks, home renovation fixtures and furniture - Copyright AFP/File CHARLY TRIBALLEAU

US President Donald Trump announced Thursday punishing tariffs on pharmaceuticals, big-rig trucks, home renovation fixtures and furniture, reviving his global trade war.

The late evening announcement is the harshest trade policy by the president since last April’s shock unveiling of reciprocal tariffs on virtually every US trading partner across the globe.

Starting October 1, “we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” the Republican wrote on his Truth Social platform.

In a separate post, he wrote of a 25 percent tariff on “all ‘Heavy (Big) Trucks’ made in other parts of the world” to support US manufacturers such as “Peterbilt, Kenworth, Freightliner, Mack Trucks and others.”

Foreign companies that compete with these manufacturers in the US market include Sweden’s Volvo and Germany’s Daimler, which includes brands Freightliner and Western Star.

Shares in both companies were sharply lower in after-hours trading in Europe.

Trump said the truck tariffs were “for many reasons, but above all else, for National Security purposes!”

Earlier this year, the Trump administration launched a so-called Section 232 probe into imports of trucks to “determine the effects of national security,” setting the stage for Thursday’s announcement.

Section 232 is a trade law provision that gives the president broad authority to impose tariffs or other restrictions on imports when they’re deemed a threat to national security.

Trump has made extensive use of Section 232 to initiate investigations and impose tariffs on imported goods as part of his efforts to bolster US manufacturing and punish countries that he says are taking advantage of the US.

The real estate tycoon also targeted home renovation materials, writing “We will be imposing a 50% Tariff on all Kitchen Cabinets, Bathroom Vanities and associated products,” as of October 1.

“Additionally, we will be charging a 30% Tariff on Upholstered Furniture,” he added.

According to the United States International Trade Commission, in 2022 imports, mainly from Asia, represented 60 percent of all furniture sold, including 86 percent of all wood furniture and 42 percent of all upholstered furniture.

Shares in home furniture retailers Wayfair and Williams Sonoma, which depend on these imported goods, tumbled in after-hours trading following the announcement.

The tariff onslaught will rekindle fears over inflation in the US economy, the world’s biggest.

Trump is on a mission to rebuild manufacturing through protectionist policies that mark a complete reversal of modern US policy to maintain an open and import-dependent economy.

His administration has imposed a baseline 10 percent tariff on all countries, with higher individualized rates on nations where exports to the US far exceed imports.

The president has also used emergency powers to impose extra tariffs on trade deal partners Canada and Mexico, as well as on China, citing concerns over fentanyl trafficking and illegal immigration.

It was not yet clear how these new tariffs that kick in next week would factor into the existing measures.

No comments: